Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

2022 ESC/ERS pulmonary hypertension guidelines incorporate changes and adaptations
focusing on clinical management https://bit. ly/3QtUvb4

Congenital hyperinsulinism (CHI) is a condition characterised by severe and recurrent
hypoglycaemia in infants and young children caused by inappropriate insulin over …

Hyperinsulinemic hypoglycemia (HH) is characterized by unregulated insulin release,
leading to persistently low blood glucose concentrations with lack of alternative fuels, which …

Mitochondrion, known as the “powerhouse” of the cell, regulates ion homeostasis, redox
state, cell proliferation and differentiation, and lipid synthesis. The inner mitochondrial …

Congenital hyperinsulinism (CHI) is a rare disease characterized by an unregulated insulin
release, leading to hypoglycaemia. It is the most frequent cause of persistent and severe …

Pulmonary arterial hypertension (PAH) is a rare and severe cardiopulmonary disease
without curative treatments. PAH is a multifactorial disease that involves genetic …

Erratum: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension:
Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the …

Background: The most common cause of persistent hypoglycemia in infancy is
hyperinsulinemic hypoglycemia. When conservative measures fail, providers often use …

Pulmonary arterial hypertension (PAH) describes a rare, progressive vascular disease
caused by the obstruction of pulmonary arterioles, typically resulting in right heart failure …